Anthony King
I am a freelance science journalist based in Dublin, Ireland. I cover a variety of topics in chemical and biological sciences, as well as science policy, health and innovation.
My articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, New York Times, EMBO Reports, Chemistry & Industry and more.
I enjoy writing on a wide breadth of subjects, from antibiotics to petrochemicals, bumblebees to asteroid composition, palaeontology to brain development. Previously I worked for a publishing company as a science editor.
My primary degree in science is from Trinity College Dublin and I hold a Master’s degree in science communications from Dublin City University.
BusinessNovartis cutting up to 8000 jobs
Restructure splits commercial activities geographically instead of by treatment area
- News
European commission proposal seeks to cut EU pesticide use in half by 2030
Ambitious targets will rely on roll-out of integrated pest management techniques and extra payments to farmers
- News
New questions raised over Sputnik Covid vaccine results point to fraudulent practices
Analysis comparing Sputnik results with five other Covid vaccines finds phase 3 trial outcome is highly improbable
- Business
Soapbark branches out to fill essential role in vaccine recipes
The soapbark tree has long been used in traditional medicines, but is now coveted for some of our newest vaccines
- News
Question marks over cannabidiol’s safety in food, European agency finds
Food safety body has already received more than 150 applications to add CBD to food products
- Research
Gene therapy showcases technique to extend life in mice
Lab mice lived significantly longer after receiving one of two genes, delivered using a mouse herpes virus
- Business
What is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
- News
Hope stirs anew for Australian research following election
Labor party’s win leads to cautious optimism about science funding and climate policies
- Research
All of life’s nucleic acids could have extraterrestrial origins
All five nucleobases of RNA and DNA found in three meteorites
- Business
UK takes subscription approach for new antibiotics
Decoupling payment from prescriptions helps preserve last-line antibiotics and encourage R&D
- Research
Discovery of microplastics in people raises difficult questions about health implications
Scientists keep finding tiny polymer particles in lungs, blood and placentas – but what does that mean means for people’s health?
- Business
War in Ukraine prompts companies to quit Russia
Sectors supplying medicines and food try to reduce impact on civilians
- Business
Moderna sued over Covid-19 vaccine-related patents
Arbutus and Genevant say lipid nanoparticles that protect mRNA infringe six key patents
- Research
Nanobots snap up pollutants with their polymer ‘hands’ to clean up water
Magnetically-guided system can trap arsenic and herbicide atrazine
- Business
Ukraine invasion rattles global supply chains
Russia’s war against Ukraine will impact supplies of metals, noble gases and more
- Research
Extent of pharmaceutical pollution on every continent on Earth revealed
Largest study of its kind creates map of drug contamination hotspots
- Research
Array of compounds found in plastics promote fat cell formation in vitro
A third of thousands of chemicals that leach from consumer polymers linked to the development of fat cells
- Business
Trials start of mRNA vaccine for HIV
First steps towards protection from the many and variable viral strains
- News
Explainer: How do the Covid vaccines measure up against each other and omicron?
Looking at how the evidence stacks up for vaccines against variants and how their performance holds up over time
- Research
Engineered antibody that snags sperm could be an effective non-hormonal contraceptive
Approach could offer new method of contraception for women
